The most common adverse effects of<unk>  are similar to other NRTI's and includes headache, neutropenia, anemia, nausea, vomiting, myopathy and nail pigmentation. More serious and potentially life-threatening adverse effects reported include lactic acidosis with hepatic steatosis, but this rare adverse event is mostly associated with Zidovudine. HIV-positive patients with chronic hepatitis B virus (HBV) infections are at risk for potential flares of hepatitis that can occur with abrupt discontinuation of<unk>  because<unk>  is also used in low doses for treatment against active HBV.
Lamivudine/zidovudine
Lamivudine/tenofovir
Abacavir/lamivudine
Lamivudine/raltegravir
Doravirine/lamivudine/tenofovir
Dolutegravir/lamivudine
Lamivudine/nevirapine/zidovudine
Abacavir/lamivudine/zidovudine